Downregulation of p38 kinase pathway by cAMP response element-binding protein protects HL-60 cells from iron chelator-induced apoptosis.

S. Choi,Bum Su Kim,M. Song,E. Choi,H. Oh,June-Hyung Lyou,Weon-Cheol Han,H. Moon,Tae Hyeon Kim,Jaemin Oh,Hun-taeg Chung,C. Jun

DOI: https://doi.org/10.1016/S0891-5849(03)00503-3

2003-11-15

Abstract:

What problem does this paper attempt to address?

Frailty Modifies the Intervention Effect of Chair Yoga on Pain among Older Adults with Lower Extremity Osteoarthritis: Secondary Analysis of a Nonpharmacological Intervention Trial.

Juyoung Park,Diane G. Sherman,George Agogo,Emiel O. Hoogendijk,Zuyun Liu

DOI: https://doi.org/10.1016/j.exger.2020.110886

IF: 4.253

2020-01-01

Experimental Gerontology

Abstract:Objective: In an 8-week nonpharmacological pain intervention trial among older adults with lower extremity osteoarthritis (OA), we aimed to examine: a) the baseline frailty level of the participants; b) whether such intervention is more beneficial for baseline frailer older adults than for their counterparts with less frailty; and c) whether the intervention could also alter frailty. Methods: Participants were randomly assigned to either chair yoga (CY) or health education program (HEP) groups and attended twice-weekly 45-minute CY or HEP sessions for 8 weeks. Following a standard procedure, 82 variables were used to construct a frailty index (FI, 0-1). Primary outcomes were: Western Ontario and McMaster Universities (WOMAC) pain and pain interference. Linear mixed-effects models were used to evaluate the modifying effect of baseline frailty on the intervention effect of CY on primary outcomes. Similar models were used to evaluate the effect of CY on frailty. Results: A total of 112 participants (n = 63 CY, n = 49 HEP; 75.3 [SD = 7.5] years) with 85 females (75.9%) were included. The mean values of baseline FI for the CY and HEP groups were similar (0.428 [0.05] and 0.433 [0.05], P = 0.355). Each 0.01 increment in baseline FI was associated with higher WOMAC pain (beta = 0.28, P < 0.001) and pain interference (beta = 0.51, P < 0.001). There was a significant interaction effect between intervention, time, and baseline FI (P = 0.020 for WOMAC pain; P = 0.010 for pain interference), indicating that participants with higher level of baseline FI had greater declines in WOMAC pain and pain interference. There was no significantly greater decline in FI for the CY group compared to the HEP group (between-group difference - 0.01; P = 0.509) and there were no significant trend changes in FI (P for interaction = 0.605). Conclusions: Frailty modifies the intervention effect of CY on pain among older adults with lower extremity OA, underscoring the importance of assessing frailty to improve the management of pain in this population.
Influence of Yoga on Cancer-Related Fatigue and on Mediational Relationships Between Changes in Sleep and Cancer-Related Fatigue: A Nationwide, Multicenter Randomized Controlled Trial of Yoga in Cancer Survivors

Po-Ju Lin,Ian R. Kleckner,Kah Poh Loh,Julia E. Inglis,Luke J. Peppone,Michelle C. Janelsins,Charles S. Kamen,Charles E. Heckler,Eva Culakova,Wilfred R. Pigeon,Pavan S. Reddy,Michael J. Messino,Rakesh Gaur,Karen M. Mustian

DOI: https://doi.org/10.1177/1534735419855134

2019-01-01

Integrative Cancer Therapies

Abstract:Background: Cancer-related fatigue (CRF) often co-occurs with sleep disturbance and is one of the most pervasive toxicities resulting from cancer and its treatment. We and other investigators have previously reported that yoga therapy can improve sleep quality in cancer patients and survivors. No nationwide multicenter phase III randomized controlled trial (RCT) has investigated whether yoga therapy improves CRF or whether improvements in sleep mediate the effect of yoga on CRF. We examined the effect of a standardized, 4-week, yoga therapy program (Yoga for Cancer Survivors [YOCAS©®]) on CRF and whether YOCAS©®-induced changes in sleep mediated changes in CRF among survivors. Study Design and Methods: Four hundred and ten cancer survivors were recruited to a nationwide multicenter phase III RCT comparing the effect of YOCAS©® to standard survivorship care on CRF and examining the mediating effects of changes in sleep, stemming from yoga, on changes in CRF. CRF was assessed by the Multidimensional Fatigue Symptom Inventory. Sleep was assessed via the Pittsburgh Sleep Quality Index. Between- and within-group intervention effects on CRF were assessed by analysis of covariance and 2-tailed t test, respectively. Path analysis was used to evaluate mediation. Results: YOCAS©® participants demonstrated significantly greater improvements in CRF compared with participants in standard survivorship care at post-intervention ( P < .01). Improvements in overall sleep quality and reductions in daytime dysfunction (eg, excessive napping) resulting from yoga significantly mediated the effect of yoga on CRF (22% and 37%, respectively, both P < .01). Conclusions: YOCAS©® is effective for treating CRF among cancer survivors; 22% to 37% of the improvements in CRF from yoga therapy result from improvements in sleep quality and daytime dysfunction. Oncologists should consider prescribing yoga to cancer survivors for treating CRF and sleep disturbance.

oncology,integrative & complementary medicine
EFFECT OF CHAIR YOGA ON FRAILTY IN OLDER ADULTS WITH LOWER EXTREMITY OSTEOARTHRITIS: RANDOMIZED CLINICAL TRIAL

Juyoung Park,Zuyun Liu,Edgar R Vieira,Patricia Liehr

DOI: https://doi.org/10.1093/geroni/igz038.2527

2019-01-01

Innovation in Aging

Abstract:Abstract This study examined whether chair yoga (CY) could reduce severity of frailty in community-dwelling older adults with lower extremity osteoarthritis (OA). Participants were randomly assigned to CY or health education program (HEP) at each of two sites and attended twice-weekly 45-minute sessions for 8 weeks. Data were collected at baseline and 4 and 8 weeks. For primary analysis, followed by Rockwood’s suggesiton, 97 deficits/variables measuring OA symptoms, physical function, balance, fatigue, depression, social activities, and life satisfaction were used to construct a frailty index, ranging from 0 to 1. Fewer deficits/variables were used to construct three alternative versions of the index. Linear mixed-effects models with random intercept were used to analyze longitudinal repeated outcome measures. A total of 112 participants (n = 63 CY, n = 49 HEP; 75.3[7.5] years; 76% female, 46% Hispanic) completed the study. After adjusting for site, cohort effect, and baseline of frailty, there was no significantly greater decline in frailty in the CY group compared to the HEP group (between-group difference, -0.019; 95% CI, -0.063 to 0.025) or the trend of changes in the index (p for interaction = .489). Additional adjustment for baseline characteristics (age, gender, ethnicity, marital status, living alone, health status, pain medication) did not change results substantially. Secondary analysis of three alternative versions of the index indicated similar nonsignificant changes. Thus, an 8-week CY intervention did not reduce severity of frailty in older adults with lower extremity OA. A longer duration of CY with a larger sample size is needed.
Frailty Modifies Effects of Chair Yoga on Chronic Pain in Older Adults with Osteoarthritis

Juyoung Park,Zuyun Liu

DOI: https://doi.org/10.1093/geroni/igaa057.865

2020-01-01

Innovation in Aging

Abstract:Abstract As a secondary analysis, this study used data from our previous 8-week chair yoga (CY) intervention trial with two-arm, access-blinded randomized controlled trial to examine modifying effect of baseline frailty on intervention effects of CY on pain and pain interference (i.e., consequences of pain on relevant aspects of life). Using the cumulative frailty index (FI) approach, we constructed the FI using 82 comprehensive deficits, including physical function, balance, fatigue, emotional well-being, and social activity. We calculated FI at baseline, 4 weeks, and 8 weeks. A linear mixed-effects model with random intercept was used, adjusting for research sites, cohort effect, and time. To test for potential modifying effects of baseline FI on the intervention effect by CY, we added a three-way interaction term: intervention (CY vs. Health Education Program), time, and baseline FI. A total of 112 participants (M = 75.3[7.5] years; 76% female, 40% White, 46% Hispanic) completed the study. Each 0.01 increment in baseline FI was associated with higher pain (β = 0.28, p < .001) and pain interference (β = 0.51, p < .001). There was a significant interaction effect among intervention, time, and baseline FI (p = .02 for pain, p = .01 for pain interference), indicating that participants with higher levels of baseline FI had greater declines in pain and pain interference. Frailty modified the intervention effect of CY on pain in older adults with lower extremity osteoarthritis, underscoring the importance of assessing frailty to improve management of pain in the population.
Denervation time and muscle restitution.

G. C. Knowlton

DOI: https://doi.org/10.1152/AJPLEGACY.1951.168.1.245

1951-12-31

Abstract:
[Efficacy of a smoking relapse prevention program by postdischarge telephone contacts: a randomized trial].

S. Hasuo,Hideo Tanaka,A. Oshima

2004-06-01

Abstract:OBJECTIVES This randomized controlled trial assessed the efficacy of a smoking relapse prevention program featuring 3 postdischarge telephone contacts with subjects who had quit smoking on hospitalization. METHODS Patients were randomly assigned to public health nurse-mediated behaviorally oriented in-patient counseling focused on relapse prevention (control group, n = 49), or the same inpatient counseling with postdischarge telephone contacts at 7, 21 and 42 days after discharge (intervention group, n = 57). The main outcome measure, smoking cessation rate, was obtained from self-reports at 3, 6 and 12 months after discharge. Smoking cessation at 12 months after discharge was confirmed by urinary nicotine concentration. RESULTS At 3, 6 and 12 months smoking cessation rates were 83%, 63% and 56% for the intervention group, and 76%, 65% and 51% for control group. After adjustment for sex, age, having any complication, number of family members, smoking status on admission, strength of nicotine dependence and self confidence to quit smoking, the odds ratio of cessation among the intervention group were 1.46 (95% confidence interval (CI): 0.48-4.47), 0.82 (95% CI: 0.31-2.17) and 0.99 (95% CI: 0.40-2.45) at 3, 6 and 12 months after discharge, respectively. CONCLUSION This program had limited efficacy to maintain postdischarge smoking abstinence. We should re-consider the modality of smoking cessation program for relapse prevention among hospitalized patients.
The influence of yoga and cognitive behavioral therapy on mediational relationships between insomnia and cancer-related fatigue: A URCC NCORP RCT in 550 cancer survivors.

Po-Ju Lin,Brian James Altman,Richard Francis Dunne,Lindsey Jean Mattick,Alisha Chakrabarti,Stephen Rajan Samuel,Umang Gada,Eva Culakova,Anthony John Jaslowski,Charles S. Kuzma,Karen Michelle Mustian

DOI: https://doi.org/10.1200/jco.2024.42.16_suppl.12015

IF: 45.3

2024-06-01

Journal of Clinical Oncology

Abstract:12015 Background: Cancer-related fatigue (CRF) often co-occurs with insomnia and both are incapacitating adverse toxicities of cancer and its treatment which may persist months and years after the completion of treatment. Yoga and Cognitive Behavioral Therapy for Insomnia (CBT-I) are promising behavioral approaches for improving CRF and insomnia among cancer survivors. However, the influence of changes in insomnia resulting from participating in yoga or CBT-I on the subsequent changes in CRF is not fully understood. Methods: We conducted mediation analyses on data collected from a multicenter phase III RCT among cancer survivors who were randomized to receive 1) Yoga for Cancer Survivors (YOCAS, 75-min./session, 2x/wk. for 4 wks.), 2) CBT-I (90-min./session, 1x/wk. for 8 wks.), or 3) a behavioral placebo (ASCO recommended Survivorship Education, 75-min/session, 2x/wk. for 4 wks.). Brief Fatigue Inventory and Insomnia Severity Index were used to assess CRF and insomnia, respectively, at pre-, mid-, and post-intervention. Causal mediation analyses were conducted to estimate the influence of changes in insomnia at mid-intervention resulting from participating in YOCAS, CBT-I, or behavioral placebo on subsequent changes in CRF at post-intervention. Results: 550 survivors (93% female; mean age 57 years; 75% were breast cancer survivors) completed baseline and post-intervention assessments. YOCAS, compared to placebo, significantly improved CRF and insomnia at mid-intervention (CRF: -0.38±0.16, p = 0.01; Insomnia: -1.15±0.35, p < 0.01) and post-intervention (CRF: -0.35±0.17, p = 0.03; Insomnia: -1.43±0.41, p < 0.01). Among YOCAS participants, improvement in insomnia at mid-intervention significantly influenced the subsequent reduction in CRF (-0.14±0.06, p = 0.01) and accounted for 37% (95% CI: 0% - 78%) of the total reduction in CRF at post-intervention. CBT-I, compared to placebo, also significantly improved CRF and insomnia at mid- (CRF: -0.32±0.18, p = 0.06; Insomnia: -2.64±0.40, p < 0.01) and post-intervention (CRF: -0.59±0.18, p < 0.01; Insomnia: -4.95±0.46, p < 0.01). Among CBT-I participants, the improvement in insomnia at mid-intervention significantly influenced the subsequent reduction in CRF (-0.40±0.09, p < 0.01) and accounted for 60% (95% CI: 21% - 99%) of the total reduction in CRF at post-intervention. Conclusions: Both YOCAS and CBT-I effectively improve CRF and insomnia among survivors. 37%-60% of the reduction in CRF resulting from participating in YOCAS or CBT-I is due to improvement in insomnia. Clinicians should consider prescribing YOCAS yoga or CBT-I for survivors who experience CRF and insomnia. Clinical trial information: NCT02613364 .

oncology
Interaction of benzodiazepines with mouse macrophages.

F. Zavala,J. Haumont,M. Lenfant

DOI: https://doi.org/10.1016/0014-2999(84)90059-1

IF: 5.195

1984-11-27

European Journal of Pharmacology

Abstract:
Long-Term Yogic Intervention Improves Symptomatic Scale and Quality of Life by Reducing Inflammatory Cytokines and Oxidative Stress in Breast Cancer Patients Undergoing Chemotherapy and/or Radiotherapy: A Randomized Control Study

Mayank Jain,Archana Mishra,Vishnu Yadav,Hari Shyam,Shailendra Kumar,Pooja Ramakant,Satyendra K Mishra

DOI: https://doi.org/10.7759/cureus.33427

2023-01-05

Cureus

Abstract:INTRODUCTION: Inflammation has been associated with tumor proliferation and metastasis in breast cancer. Yoga is an ancient therapy that helps in reducing inflammation and improves the patient's quality of life (QoL) and fatigue. In the current study, we investigated the effects of long-term yogic intervention at different time points on the level of inflammatory cytokines and oxidative stress, along with the symptomatic scale and QoL in stage II/III breast cancer patients.METHODS: Ninety-six stage II/III breast cancer patients receiving chemotherapy and/or radiotherapy were enrolled and divided into two groups, non-yoga (Group I) and yoga (Group II). Participants in Group II practiced yoga five days per week for 48 weeks. The European Organisation for Research and Treatment of Cancer quality of life questionnaire (EORTC-QLQ30) was used to measure the QoL and symptomatic scale. Serum levels of pro-inflammatory cytokines, tumor necrosis factor-alpha (TNF-α), interferon-γ (IFN-γ) and granulocyte macrophage colony-stimulating factor (GM-CSF), and oxidative stress markers, superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), and nitric oxide (NO) were measured at baseline, 16, 32, and 48 weeks in both groups.RESULTS: Yoga significantly (p<0.05) reduced the level of IFN-γ, TNF-α, and MDA and improved QoL (p<0.001) and symptomatic scale (p<0.05) in Group II patients compared to Group I. NO was upregulated in Group I whereas in Group II, it was neither decreased nor increased.CONCLUSION: These findings suggest that yoga may reduce levels of inflammatory cytokines and improve QoL and symptomatic scale in breast cancer patients receiving chemotherapy and/or radiotherapy. Yoga can be an important additional therapy during cancer treatments to cope with treatment side effects including fatigue, depression, and immunological profile, which directly affects the patient's quality of life.
Yoga Therapy as an Intervention to Improve Patient-Reported Outcomes Among Adults After Treatment for Cancer: Preliminary Findings From a Trial Using Single-Subject Experimental Design

Jennifer Brunet,Julia Hussien,Anne Pitman,Amanda Wurz,Ellen Conte,Nadia Polskaia,Dugald Seely

DOI: https://doi.org/10.1177/15347354241233517

2024-02-23

Integrative Cancer Therapies

Abstract:Integrative Cancer Therapies, Volume 23, Issue , January-December 2024. Background:Cancer is a chronic condition associated with a substantial symptom burden, which can impair recovery after treatment. Investigating interventions with potential to improve self-reported disease and/or treatment effects—known as patient-reported outcomes (PROs)—is paramount to inform cancer care. The objective of this study was to evaluate the effects of a yoga therapy (YT) intervention on key PROs (ie, cancer-related fatigue, anxiety, cognitive function, depression, stress, quality of life [QoL]) among adults after treatment for cancer.Methods:Data from 20 adults (Mage = 55.74 years, 85% female; Mtime since diagnosis = 2.83 years) who had completed treatment for cancer were analyzed for this study. In this single-subject exploratory experimental study, the YT intervention comprised a 1:1 YT session (ie, 1 participant with 1 yoga therapist) followed by 6 weekly small (ie, 2–3 participants) group YT sessions. Group sessions were facilitated by the same yoga therapist who delivered participants' 1:1 session to ensure an in-depth personalized approach. PROs were assessed before (ie, pre-intervention) and after the 1:1 YT session (ie, during the intervention), as well as after the last group YT session (ie, post-intervention). Hierarchical linear modeling was used to analyze the data.Results:Participants showed improvements in cancer-related fatigue, state anxiety, trait anxiety, perceived cognitive impairments, impacts of perceived cognitive impairments on QoL, and 1 dimension of QoL (ie, functional wellbeing) over time. Notably, cancer-related fatigue and state anxiety increased immediately after the 1:1 session, but showed greater improvements over time afterward (ie, during the intervention phase). No changes were observed for the remaining PROs.Conclusion:Although results require confirmation in future trials, this study highlights the importance of continuing to investigate YT as an intervention to enhance important PROs (ie, cancer-related fatigue and state anxiety) after treatment for cancer. More research is needed to identify additional beneficial effects and factors that influence participants' responses to 1:1 and group YT (ie, moderators and mediators).Registration number:ISRCTN64763228Date of registration:December 12, 2021. This trial was registered retrospectively.URL of trial registry record:https://www.isrctn.com/ISRCTN64763228Published Protocol:Brunet, J., Wurz, A., Hussien, J., Pitman, A., Conte, E., Ennis, J. K., . . . & Seely, D. (2022). Exploring the Effects of Yoga Therapy on Heart Rate Variability and Patient-Reported Outcomes After Cancer Treatment: A Study Protocol. Integrative Cancer Therapies, 21, 15347354221075576.

oncology,integrative & complementary medicine
Exploring the Effects of Yoga Therapy on Heart Rate Variability and Patient-Reported Outcomes After Cancer Treatment: A Study Protocol

Jennifer Brunet,Amanda Wurz,Julia Hussien,Anne Pitman,Ellen Conte,Julie K. Ennis,Christophe L. Herry,Andrew J. E. Seely,Dugald Seely

DOI: https://doi.org/10.1177/15347354221075576

2022-01-01

Integrative Cancer Therapies

Abstract:Background: Following cancer treatment, adults commonly report worsened patient-reported outcomes (PROs) such as anxiety, stress, depression, persistent and upsetting cognitive complaints, unrelenting fatigue, and reduced quality of life. Poorer PROs are associated with disrupted autonomic nervous system functioning as measured by heart rate variability (HRV), both of which have been associated with greater morbidity and mortality. Interventions to improve HRV and PROs among adults following cancer treatment are needed. Yoga therapy holds promise as an intervention to improve HRV and PROs. Therefore, we conducted a single-subject exploratory experimental study to investigate the effects of yoga therapy on HRV and specific PROs (ie, cancer-related fatigue, anxiety, cognitive function, depression, stress, quality of life) in adults treated for cancer. To reduce publication bias, improve reproducibility, and serve as a reference for forthcoming reporting of study results, we present the study protocol for this study herein. Methods: Participants were adults who completed cancer treatment that were recruited from the Ottawa Integrative Cancer Centre. Consenting and eligible participants received one 1:1 yoga therapy session (ie, 1 participant, 1 Yoga Therapist) and 6 weekly group-based yoga therapy sessions (ie, 2-3 participants, 1 Yoga Therapist). Participants completed assessments 7 times: 3 times prior to the program (ie, −6 weeks, −3 weeks, immediately prior to the 1:1 yoga therapy session), immediately following the 1:1 yoga therapy session, prior to the first group-based yoga therapy session, after the last group-based yoga therapy session, and at a 6-week follow-up. Hierarchical linear modeling will be used to test the average effects of the yoga therapy program across participants. Discussion: This study will explore several novel hypotheses, including whether yoga therapy can improve HRV and/or specific PROs among adults treated for cancer acutely (ie, during a 1:1 yoga therapy session) and/or through repeated exposure (ie, after completing 6 weeks of group-based yoga therapy). Although the findings will require confirmation or refutation in future trials, they may provide initial evidence that YT may benefit adults treated for cancer. Trial registration: ISRCTN registry, ISRCTN64763228. Registered on December 12, 2021. This trial was registered retrospectively. URL of trial registry record: https://www.isrctn.com/ISRCTN64763228

oncology,integrative & complementary medicine
Yoga versus iPad active control for fatigue in paediatric cancer therapy: a randomised controlled trial

Tal Schechter,Cassandra Tardif-Theriault,Nicole Culos-Reed,Victor Lewis,Andrea Orsey,Caroline Diorio,George A Tomlinson,Lillian Sung

DOI: https://doi.org/10.1136/spcare-2023-004609

2023-12-30

Abstract:Objectives: The primary objective was to determine if individualised yoga for hospitalised children receiving intensive chemotherapy was associated with less fatigue using the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale (PedsQL MFS) compared with iPad control. Methods: This was a multicentre randomised controlled trial of individualised yoga in paediatric patients aged 8-18 years who were inpatients receiving intensive chemotherapy for leukaemia, lymphoma or haematopoietic cell transplantation. Participants were randomised to yoga or iPad groups; allocated programme was delivered individually by trained yoga instructors 5 days/week for 21 days. The primary outcome was day 21 guardian-reported general fatigue using the PedsQL MFS. Secondary outcomes included day 21 PedsQL sleep/rest and cognitive fatigue, Fatigue Scale and PedsQL Acute Cancer Module, and systemic opioid administration. Results: The study was closed early for poor accrual when 125/210 planned participants had been enrolled and randomised to yoga (n=62) or iPad (n=63). Guardian-reported PedsQL MFS general fatigue scores on day 21 were not significantly different between groups (adjusted difference 7.2, 95% CI -2.6 to 16.9) in favour of yoga. However, day 21 cognitive fatigue (adjusted difference 9.0, 95% CI 0.9 to 17.1), cognitive problems (adjusted difference 11.2, 95% CI 3.5 to 19.0) and communication (adjusted difference 10.6, 95% CI 0.8 to 20.4) were significantly better in the yoga compared with the iPad group. There were no significant differences in the other secondary outcomes including PedsQL sleep/rest fatigue (adjusted difference 4.9, 95% CI -3.5 to 13.3). Conclusions: The effect of individualised yoga on general fatigue is uncertain in paediatric patients receiving intensive chemotherapy. However, yoga significantly improved cognitive fatigue and cognitive problems. Trial registration number: NCT02134782.
PKR as a Regulator of Inflammasome Activation

Z. Manzoor,Y. Koh

DOI: https://doi.org/10.4167/JBV.2013.43.2.145

2013-06-01

Abstract:Detection of pathogen by pattern recognition receptors leads to activation of inflammasome which plays a crucial role in immune system. The inflammasome regulates the release of cytokines, such as interleukin (IL)-1β, IL-18 and high-mobility group box 1 (HMGB1). Double-stranded RNA-dependent protein kinase (PKR) is a critical component of an inflammatory complex. Recently, the critical role of PKR was reported in regulation of multiple inflammasomes.
Effect of Yoga on Sleep Quality among Adult Cancer Patients: A Systematic Review Protocol

Gina Alexander,Suzy Lockwood

DOI: https://doi.org/10.11124/jbisrir-2013-612

2013-01-01

JBI Database of Systematic Reviews and Implementation Reports

Abstract:Review question/objective The objective of this review is to identify the effectiveness of yoga practice on sleep quality. More specifically, the objective is to identify the effectiveness of yoga practice in adult cancer patients over the age of 18 who are concurrently undergoing conventional treatment for cancer. The specific review question is: What is the effect of yoga practice on sleep quality in adult cancer patients over the age of 18 who are concurrently undergoing conventional treatment for cancer? Background Although research and technological advances have fostered improvement in the biomedical care delivered to cancer patients, achievements in the care of psychological and social needs faced throughout the cancer experience have not been realized.1 These psychosocial needs stem from lack of information regarding diagnosis, prognosis, and treatment plans; emotional strain and uncertainty; lack of transportation to clinical appointments; disruptions in daily life, including work, school, and family dynamics; and inadequate financial resources to meet the demands of therapy and follow‐up recommendations.1 The cumulative effect of these stressors has a negative impact on sleep patterns, contributing significantly to the poor sleep quality often reported by cancer patients.2‐9 The importance of sleep for optimal healing and recovery of cancer patients cannot be overstated, as indicated in a recent review regarding the experience of sleep‐wake disturbances reported by adults with cancer.7 Specific concerns described by these patients included difficulty falling asleep, premature awakenings, nonrestorative sleep, daytime drowsiness, and persistent fatigue. A recent epidemiologic investigation of the health of cancer survivors one year following diagnosis revealed a significant correlation between insomnia and increased risk of death and loss to follow‐up.10 Given the effects of insomnia on psychosocial indicators (quality of life and mood, among others), cancer patients consider diminished sleep quality one of the most distressing symptoms they face, particularly when sleep disturbances interfere with the management of other symptoms and persist after treatment. 11 In the midst of treatment and recovery, some individuals turn to complementary and alternative medicine (CAM) to relieve recalcitrant symptoms and to enhance overall well‐being. Recent population estimates indicate that among patients diagnosed with cancer, over 39% of those in the United States and 35.9% of those in Europe have used CAM.12,13 CAM consists of a number of therapeutic formats, ranging from whole systems to herbal treatments to mind‐body therapies.14 The practice of yoga is a form of mind‐body therapy, in which the power of concentrated thought and mindfulness triggers a hormonal and immunological response, evoking a state of motor and emotional arousal with associated powerful effects on the body.14‐15 Core components of yoga include meditation, physical postures (asanas), and breathing exercises (pranayama) designed to promote mental, physical, and spiritual well‐being.15 As a framework for understanding the therapeutic mechanisms of yoga, the field of psychoneuroimmunology (PNI) emphasizes the dynamic physiological impact of emotions on the immune response.16‐19 As posited by the PNI framework, the nervous, immune, and endocrine systems are intricately interconnected.20 The cumulative effect of negative emotions and chronic stress stimulate the sympathetic nervous system, causing an increased circulation of stress hormones and impairing the body's ability to heal and function normally.21 This cascade of events places individuals at greater risk for developing inflammatory patterns of dysfunction and disease.22 Interventions that induce relaxation, positive emotion, and overall well‐being diminish the activation of the sympathetic nervous system, thereby alleviating the effects of stress, fostering a return to hormonal balance, and minimizing the inflammatory response.23 Previous research among individuals with cancer suggests that the practice of yoga yields a range of mental and physical benefits, such as improved quality of life; reduced fatigue, stress, and depression; and enhanced physical function. 24‐30 Although evidence suggests that yoga practice may lead to improved sleep quality among individuals with cancer,31‐33 no systematic review examining the effect of yoga practice on sleep quality among adult cancer patients was identified by initial searches of the Cochrane Library of Systematic Reviews, JBI Library of Reviews, CRD DARE database, CRD PROSPERO database, or other bibliographic databases, such as EMBASE, CINAHL, PubMed/MEDLINE. The proposed systematic review will contribute to the understanding of the effect of yoga practice on adult cancer patients undergoing treatment and will also identify areas for further research.
Effects of yoga, cognitive behavioral therapy, and a behavioral placebo on sleep: A nationwide multicenter phase III RCT in cancer survivors.

Po-Ju Lin,Charles E. Heckler,Eva Culakova,Huiwen Xu,Richard Francis Dunne,Nikesha Gilmore,Sara Hardy,Amber Kleckner,Ian Kleckner,Kah Poh Loh,Michelle Christine Janelsins,Luke Joseph Peppone,Amy C. Vander Woude,Alison Katherine Conlin,Anthony John Jaslowski,Karen Michelle Mustian

DOI: https://doi.org/10.1200/jco.2021.39.15_suppl.12017

IF: 45.3

2021-05-20

Journal of Clinical Oncology

Abstract:12017 Background: Patients commonly experience impaired sleep throughout cancer treatment and for years into survivorship. Impaired sleep may mediate other cancer-related symptoms and can lead to the inability to complete daily activities and lower quality of life. More effective non-pharmacological treatment options for impaired sleep are needed. We conducted a nationwide, multicenter, phase III randomized controlled trial (RCT) comparing the effects of yoga (Yoga for Cancer Survivors; YOCAS), cognitive behavioral therapy for insomnia (CBT-I), and a behavioral placebo on impaired sleep in cancer survivors. Methods: This RCT was conducted via the URCC NCORP Research Base. Participants were cancer survivors 2-60 months post-treatment with insomnia. They were randomized to 1) YOCAS (75-min session biweekly for 4 wks), 2) CBT-I (90-min session weekly for 8 wks), and 3) behavioral placebo (survivorship health education per ASCO guidelines; 75-min session biweekly for 4 wks). Sleep efficiency, sleep duration, wake after sleep onset (WASO), and sleep latency were assessed via actigraphy at baseline and post-intervention. Actigraphs were worn on the non-dominant wrist 24 hours a day for 7 days. Linear mixed models were used to assess intervention effects on sleep outcomes. Results: 740 survivors were enrolled (93% female, mean age 56±11 years, 73% breast cancer). Results revealed significant group differences among survivors in the 3 arms in sleep efficiency, sleep duration, and WASO (all p 0.05). YOCAS and CBT-I subjects maintained sleep efficiency (mean change= -0.8% and -0.03%, respectively, all p>0.05) while behavioral placebo subjects significantly reduced sleep efficiency (mean change= -3.4%, p<0.01). When controlling for baseline, YOCAS and CBT-I subjects demonstrated better sleep efficiency compared to behavioral placebo subjects at post-intervention (all p 0.05) while CBT-I and behavioral placebo subjects significantly reduced sleep duration (mean change= -20.3 minutes and -26.6 minutes, respectively, all p<0.01). When controlling for baseline, YOCAS subjects demonstrated longer sleep duration compared to CBT-I and behavioral placebo subjects at post-intervention (all p<0.05). There were no significant within-group changes in WASO over time in the 3 arms. When controlling for baseline, CBT-I subjects demonstrated a trend toward lower WASO compared to YOCAS (p=0.07) and behavioral placebo (p=0.05) subjects at post-intervention. Conclusions: Both YOCAS and CBT-I maintained sleep efficiency and/or sleep duration among cancer survivors. Oncologists should consider prescribing yoga and CBT-I for treating impaired sleep in cancer survivors. Funding: NCI UG1CA189961, R01CA181064, T32CA102618. Clinical trial information: NCT02613364.

oncology
Sodium dependence of intermedin action on melanophores in tissue culture.

R. R. Novales,B. J. Novales

DOI: https://doi.org/10.1016/0016-6480(61)90041-7

IF: 3.255

1961-06-01

General and Comparative Endocrinology

Abstract:
Yoga Therapy During Chemotherapy for Early-Stage and Locally Advanced Breast Cancer

Samantha K. Greaney,Neha Amin,Bethany C. Prudner,Maggie Compernolle,Linda J. Sandell,Susan C. Tebb,Katherine N. Weilbaecher,Peri Abeln,Jingqin Luo,Yu Tao,Angela C. Hirbe,Lindsay L. Peterson

DOI: https://doi.org/10.1177/15347354221137285

2022-11-22

Integrative Cancer Therapies

Abstract:Integrative Cancer Therapies, Volume 21, Issue , January-December 2022. Background:Chemotherapy is associated with decreased quality of life (QOL), fatigue, depression, and weight gain in patients with breast cancer. Weight gain is associated with poorer prognosis. Yoga improves QOL, fatigue, and mood in women with breast cancer but its effect on treatment-related weight gain has not been studied. The aim of this trial was to determine the feasibility of personalized yoga therapy in women receiving treatment for early-stage or locally advanced breast cancer and assess its impact on weight gain.Methods:Thirty women were randomized 1:1 to receive yoga therapy by a certified yoga therapist during treatment or a control group. Participants in the yoga arm were asked to complete three 30 minute yoga sessions weekly (which included movement, breath work, mindfulness, and relaxation) throughout adjuvant or neoadjuvant chemotherapy (N = 29) or endocrine (N = 1); the control arm received breast cancer treatment without yoga. For comparability between participants randomized to yoga therapy, the single patient treated with endocrine therapy was excluded from the analysis. Primary outcomes were feasibility and weight change. Additional outcomes were mood, fatigue, QOL, serum tumor necrosis factor-alpha (TNF-alpha), and C-reactive protein (CRP) as immune mediator biomarkers.Results:Mean age was 51.6 years, 75.9% were white and 24.1% were people of color, reflecting the cancer center population. 80% had stage II-III disease. Enrollment was completed in 9 months. Compliance was lower than predicted; however, participants participated in on average 1.7 yoga sessions/week for a mean 15.6 weeks duration. There were no adverse events. Control arm participants gained on average 2.63% body weight during treatment while yoga participants lost 0.14% body weight (weight change = −0.36 in yoga arm vs. 2.89 in standard of care arm, Wilcoxon rank sum test P = .024). Control participants reported increased fatigue and decreased QOL, while yoga participants reported no change in QOL. No significant change in TNF-alpha or CRP was noted in either arm.Conclusion:This feasibility study suggests that personalized yoga therapy is beneficial for QOL and weight maintenance among women undergoing chemotherapy for early-stage or locally advanced breast cancer. Weight maintenance associated with yoga therapy may be of clinical significance in this population given the poorer prognosis associated with weight gain in breast cancer survivors.Trial Registration:NIH Clinicaltrials.gov #NCT03262831; August 25, 2017. https://clinicaltrials.gov/ct2/show/NCT03262831

oncology,integrative & complementary medicine
Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells.

G. Nicolson,K. Dulski,J. Trosko

DOI: https://doi.org/10.1073/PNAS.85.2.473

Abstract:A series of rat 13762NF mammary adenocarcinoma cell sublines and clones of various spontaneous pulmonary metastatic potentials from the mammary fat pads of syngeneic rats were examined for their intercellular junctional communication. Using the scrape-loading dye-transfer technique to introduce Lucifer yellow (Mr 457) into cells, we measured the abilities of 13762NF cells to transfer dye to adjacent cells. There was an excellent correlation between loss of Lucifer yellow dye transfer and spontaneous metastatic potential (average total volume of lung metastases inversely correlated to % cells coupled, r = 0.93; average total number of lung metastases inversely correlated to % cells coupled, r = 0.91). The data suggest that high metastatic potentials are closely correlated with loss of intercellular junctional communication in these malignant mammary tumor cells.
Instructions for use Title Luminescence of a Cooper Pair

Y. Asano,I. Suemune,H. Takayanagi,E. Hanamura

Abstract:
Yoga intervention for colorectal cancer survivors: a qualitative study exploring participants' expectations and experiences

Mirela-Ioana Bilc,Nina Pollmann,Clemens Eisenmann,Analena Buchholz,Bijay Pokhrel,Romy Lauche,Holger Cramer

DOI: https://doi.org/10.1080/07853890.2024.2397571

Abstract:Introduction: Colorectal cancer (CRC) survivors often struggle with side effects following treatment such as reduced quality of life, fatigue and psychological distress and need therefore efficient comprehensive interventions. The aim of this qualitative study was to explore CRC survivors' expectations before the yoga intervention as well as their unique experiences beyond those reported with standard questionnaires. Methods: Interpretative phenomenological approach was used in this qualitative study. Semi-structured interviews were conducted before and after a 10-week yoga program (90 min once a week, Hatha Yoga) with CRC survivors enrolled in a randomized controlled trial. Thematic analysis was used to uncover themes present in participants' accounts. Results: Nine patients participated in the interviews, mean interview duration was 27.49 min (SD = 7.71) before and 38.41 min (SD = 15.93) after the intervention. Our analysis identified following themes: (1) representations and expectations from the yoga intervention; (2) course structure and implementation; (3) perceptions and effects of the intervention; (4) differences between the study yoga intervention and other physical activities. The superordinate theme regarding effects of intervention included aspects of intervention at multiple levels such as emotional, physical, behavioral and spiritual. Conclusions: This qualitative study provides valuable insight regarding CRC survivors' expectations and experiences following a 10-week yoga intervention. While expectations varied from skepticism to specific symptom improvement, the majority of participants had a positive, open attitude towards yoga. Consistent with participants' experiences, yoga may represent a promising intervention for CRC survivors if the groups' specific concerns are taken into account.

Downregulation of p38 kinase pathway by cAMP response element-binding protein protects HL-60 cells from iron chelator-induced apoptosis.

Frailty Modifies the Intervention Effect of Chair Yoga on Pain among Older Adults with Lower Extremity Osteoarthritis: Secondary Analysis of a Nonpharmacological Intervention Trial.

Influence of Yoga on Cancer-Related Fatigue and on Mediational Relationships Between Changes in Sleep and Cancer-Related Fatigue: A Nationwide, Multicenter Randomized Controlled Trial of Yoga in Cancer Survivors

EFFECT OF CHAIR YOGA ON FRAILTY IN OLDER ADULTS WITH LOWER EXTREMITY OSTEOARTHRITIS: RANDOMIZED CLINICAL TRIAL

Frailty Modifies Effects of Chair Yoga on Chronic Pain in Older Adults with Osteoarthritis

Denervation time and muscle restitution.

[Efficacy of a smoking relapse prevention program by postdischarge telephone contacts: a randomized trial].

The influence of yoga and cognitive behavioral therapy on mediational relationships between insomnia and cancer-related fatigue: A URCC NCORP RCT in 550 cancer survivors.

Interaction of benzodiazepines with mouse macrophages.

Long-Term Yogic Intervention Improves Symptomatic Scale and Quality of Life by Reducing Inflammatory Cytokines and Oxidative Stress in Breast Cancer Patients Undergoing Chemotherapy and/or Radiotherapy: A Randomized Control Study

Yoga Therapy as an Intervention to Improve Patient-Reported Outcomes Among Adults After Treatment for Cancer: Preliminary Findings From a Trial Using Single-Subject Experimental Design

Exploring the Effects of Yoga Therapy on Heart Rate Variability and Patient-Reported Outcomes After Cancer Treatment: A Study Protocol

Yoga versus iPad active control for fatigue in paediatric cancer therapy: a randomised controlled trial

PKR as a Regulator of Inflammasome Activation

Effect of Yoga on Sleep Quality among Adult Cancer Patients: A Systematic Review Protocol

Effects of yoga, cognitive behavioral therapy, and a behavioral placebo on sleep: A nationwide multicenter phase III RCT in cancer survivors.

Sodium dependence of intermedin action on melanophores in tissue culture.

Yoga Therapy During Chemotherapy for Early-Stage and Locally Advanced Breast Cancer

Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells.

Instructions for use Title Luminescence of a Cooper Pair

Yoga intervention for colorectal cancer survivors: a qualitative study exploring participants' expectations and experiences